Tessa Jaspers and Colleagues on Current Evidence Not Supporting Routine Anti-Xa Monitoring in Use of LMWH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”A systematic review on anti-Xa monitoring in the therapeutic use of low-molecular-weight heparins
LMWHs are widely used in diverse patient groups (renal impairment, pregnancy, obesity), but the value of anti-Xa monitoring remains unclear.
This systematic review of 48 studies (RCTs and observational) found:
- Comparable bleeding and VTE rates in monitored vs. unmonitored patients.
- Frequent dose adjustments in monitored cohorts.
- Weak or absent correlation between anti-Xa levels and clinical outcomes.
Current evidence does not support routine anti-Xa monitoring for LMWH dose adjustment.”
Read the full paper in JTH.
Article: A systematic review on anti-Xa monitoring in the therapeutic use of low-molecular-weight heparins
Authors: Tessa C. C. Jaspers, P. Christian Remmelzwaal, Eefje P.S. Weersink, Karina Meijer, Nakisa Khorsand
Stay updated on all science in the field of anticoagulation with Hemostasis Today.
-
Apr 23, 2026, 17:05Veronica Sanchez: The 2026 Guideline on the Management of Dyslipidemia
-
Apr 23, 2026, 16:57Hisam Siddiqi: Review of Interactive Cases by Blood Academy First Edition
-
Apr 23, 2026, 16:55Neda K.: When to Hold Antithrombotics and Use Bridging Therapy in Surgery
-
Apr 23, 2026, 16:39Amanda Thijsen։ How Do People Feel After Donating Blood Or Plasma?
-
Apr 23, 2026, 16:36Simon Senanu: Microcytosis – Iron Deficiency vs Thalassemia
-
Apr 23, 2026, 16:26Ifeanyichukwu Ifechidere: The Framework for Mastering Coagulation Fundamentals
-
Apr 23, 2026, 16:12Fayad Al-Haimus։ HI-PEITHO Shows Reduced PE Complications Without Increased Bleeding
-
Apr 23, 2026, 16:04Hamid Yousaif Qureshi: Japanese Scientists Develop Artificial Blood
-
Apr 23, 2026, 15:5810 Treating Fairly Research Awards – ASH